- Parties: The plaintiffs were Boehringer Ingelheim (Canada) Ltd. and Boehringer Ingelheim International GmbH. The defendant was Teva Canada Limited.

- Subject Matter: This action involved the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133. This case is ongoing.

- Date: The hearing was set on Dec. 13, 2024.

- Venue: This was a federal case before the Federal Court (of Appeal).

- Amount: No financial award was specified.